- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/192 - Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
Patent holdings for IPC class A61K 31/192
Total number of patents in this class: 5397
10-year publication summary
430
|
440
|
476
|
464
|
468
|
448
|
477
|
355
|
364
|
252
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Genfit | 276 |
84 |
io Therapeutics, Inc. | 120 |
61 |
Galderma Research & Development | 398 |
55 |
Infirst Healthcare Limited | 60 |
50 |
Amylyx Pharmaceuticals Inc. | 108 |
45 |
The Regents of the University of California | 20108 |
42 |
Cymabay Therapeutics, Inc. | 112 |
42 |
United Therapeutics Corporation | 310 |
42 |
The General Hospital Corporation | 4770 |
35 |
Kenvue Brands LLC | 973 |
33 |
Teikoku Seiyaku Co., Ltd. | 180 |
31 |
The Johns Hopkins University | 5714 |
22 |
Selecta Biosciences, Inc. | 189 |
22 |
Bausch Health Ireland Limited | 795 |
22 |
Nordiccan A/S | 50 |
22 |
Allergan, Inc. | 2337 |
21 |
Rush University Medical Center | 310 |
21 |
AFT Pharmaceuticals Limited | 80 |
18 |
Sanovel Ilac Sanayi ve Ticaret A.S. | 287 |
18 |
Duke University | 3090 |
17 |
Other owners | 4694 |